Over the past decades, melanoma incidence has been increasing markedly in Europe, and continues to do so in most European countries.1 Fortunately, melanoma mortality did not rise as much as incidence, especially among females trends in mortality rates are almost flat. However, mortality rates among (elderly) men are on the rise.1,2 Men have long been known to have a worse prognosis of melanoma, and often present with thicker and nodular melanomas.3,4 These observations indicate that prevention efforts should be more specifically aimed at reducing male melanoma mortality.
|Tijdschrift||Eur J Cancer|
|Nummer van het tijdschrift||9|
|Status||Published - 2009|